Significance of serum butyrylcholinesterase levels in oral cancer

Australasian Medical Journal

Volumn 4, Issue 7, 2011, Pages 374-378

  Prabhu, K ^a   Naik, D ^a   Ray, S ^a   Vadiraj, ^a   Rao, A ^a   Kamath, A ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Butyrylcholinesterase; Oral carcinoma; Prognosis

Indexed keywords

CHOLINESTERASE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CENTRIFUGATION; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MOUTH CANCER; ORAL BIOPSY; PROGNOSIS; SERUM; SQUAMOUS CELL CARCINOMA;

EID: 79961074070     PISSN: None     EISSN: 18361935     Source Type: Journal    
DOI: 10.4066/AMJ.2011.569     Document Type: Article

References (27)

1. Petersen PE. Strengthening the prevention of oral cancer: the WHO perspective. Community Dent Oral Epidemiol. 2005;33(6):397-399.
2. Park K. Cancer. In: Park K, editor. Textbook of preventive and social medicine. 20th ed. Jabalpur: Banarsidas Bhanot Publishers; 2009. p. 332-340.
3. Miller BA. Cancer/gov [homepage on the net]. Racial/ethnic patterns of cancer in the United States, 1988:49. [cited 2010 Sep 27]. Available from: http://seer.cancer.gov/publications/ethnicity/oralcav.pdf.
4. Pitiyage G, Tilakaratne WM, Tavassoli M, Warnakulasuriya S. Molecular markers in oral epithelial dysplasia: review. J Oral Pathol Med. 2009;38(10):737-752.
5. Hengstler JG, Arand M, Herrero ME, Oesch F. Polymorphisms of N-acetyltransferases, glutathione Stransferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res. 1998;154:47-85.
6. Urade M, Uematsu T, Mima T, Ogura T, Matsuya T. Serum dipeptidyl peptidase (DPP) IV activity in hamster buccal pouch carcinogenesis with 9, 10-dimethyl-1, 2- benzanthracene. J Oral Pathol Med. 1992;21(3):109-112.
7. Prabhu K, Bhat GP. Serum total glutathione-S-transferase levels in oral cancer. J Cancer Res Ther. 2007;3(3):167-168.
8. Ferrandina G, Scambia G, Damia G, Tagliabue G, Fagotti A, Benedetti Panici P, Mangioni C, Mancuso S, D'Incalci M. Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcome. Ann Oncol. 1997;8(4):343-350.
9. Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D. et al. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat Res. 2008;638(1-2):184-194.
10. David HS, Samantha M, Gian S. Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem Int 1996;28(5):453-483.
11. Zakut H, Ehrlich G, Ayalon A, Prody CA, Malinger G, Seidman S, Ginzberg D, Kehlenbach R, Soreq H. et al. Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas. J Clin Invest. 1990;86(3):900-908.
12. Chatonnet A, Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem J. 1989;260(3):625-634.
13. Bradamante V, Smigovec E, Bukovic D, Geber J, Matanic D. Plasma cholinesterase activity in patients with uterine cervical cancer during radiotherapy. Coll Antropol. 2000;24(2):373-380.
14. Chougule A, Hussain S, Agarwal DP. Prognostic and diagnostic value of serum pseudocholinesterase, serum aspartate transaminase, and serum alinine transaminase in malignancies treated by radiotherapy. J Cancer Res Ther. 2008;4(1):21-25.
15. Bergmeyer HU. Cholinesterase. In: Whittaker M, editor. Methods of enzymatic analysis, volume IV, enzyme 2: esterases, glycosidases, lyases, ligases. 3rd ed. Weinheim:Verlag Chemie GmbH; 1984. p. 63-74.
16. Oyama T, Kawamoto T, Matsuno K, Osaki T, Matsumoto A, Isse T, Nakata S, Ozaki S, Sugaya M, Yasuda M, Yamashita T, Takenoyama M, Sugio K, Yasumoto K. A case-case study comparing the usefulness of serum trace elements (Cu, Zn and Se) and tumor markers (CEA, SCC and SLX) in non-small cell lung cancer patients. Anticancer Res. 2003; 23(1B):605-12.
17. Yanagitani N, Kaira K, Sunaga N, Naito Y, Koike Y, Ishihara S, Ishizuka T, Saito R, Mori M. Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer? Int J Clin Oncol. 2007; 2(3): 231-233.
18. Sreekantha, D'souza V, D'souza B. Hyperamylasemia in ovarian tumors -serum amylase as a marker of ovarian cancer? International J Pharm Bio sci. 2011; 2(1): 445-449.
19. Chougule A, Hussain S, Agarwal DP. Serum CEA levels as an index of disease activity in various carcinogenic conditions. J Clin Radiother Oncol. 2004;4:44.
20. Chougule A. Management of malignancies by radiotherapy and role of biochemical parameters. Asian J Exp Sci. 1999;13:39.
21. Chougule A. Role of some biochemical markers in management of malignancy. In Goel SC, editor Advances in radiation biology and peace. Uttar Pradesh: Utter Pradesh Zoological Society publishers. 1999. p. 69.
22. Hoffmann RR, Yurgel LS, Campos MM. Endothelins and their receptors as biological markers for oral cancer. Oral Oncol. 2010;46(9):644-647.
23. Cokugras AN. Butyrylcholinesterase: structure and physiological importance. Turk J Biochem 2003;28:54-61.
24. Small DH, Michaelson S, Sberna G. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem Int. 1996;28(5-6):453-483.
25. McQueen MJ. Clinical and analytical considerations in the utilization of cholinesterase measurements. Clin Chim Acta. 1995;237(1-2):91-105.
26. Soreq H, Lapidot-Lifson Y, Zakut H. A role for cholinesterases in tumorigenesis? Cancer Cells. 1991;3(12):511-516.
27. Syed M, Fenoglio-Preiser C, Skau KA, Weber GF. Acetylcholinesterase supports anchorage independence in colon cancer. Clin Exp Metastasis. 2008;25(7):787-798.